Abstract:RNA modifications are mostly dynamically reversible post-transcriptional modifications, of which m6A is the most prevalent in eukaryotic mRNAs. A growing number of studies indicate that RNA modification can finely tune gene expression and modulate RNA metabolic homeostasis, which in turn affects the self-renewal, proliferation, apoptosis, migration, and invasion of tumor cells. Endometrial carcinoma (EC) is the most common gynecologic tumor in developed countries. Although it can be diagnosed early in the onset and have a preferable prognosis, some cases might develop and become metastatic or recurrent, with a worse prognosis. Fortunately, immunotherapy and targeted therapy are promising methods of treating endometrial cancer patients. Gene modifications may also contribute to these treatments, as is especially the case with recent developments of new targeted therapeutic genes and diagnostic biomarkers for EC, even though current findings on the relationship between RNA modification and EC are still very limited, especially m6A. For example, what is the elaborate mechanism by which RNA modification affects EC progression? Taking m6A modification as an example, what is the conversion mode of methylation and demethylation for RNAs, and how to achieve selective recognition of specific RNA? Understanding how they cope with various stimuli as part of in vivo and in vitro biological development, disease or tumor occurrence and development, and other processes is valuable and RNA modifications provide a distinctive insight into genetic information. The roles of these processes in coping with various stimuli, biological development, disease, or tumor development in vivo and in vitro are self-evident and may become a new direction for cancer in the future. In this review, we summarize the category, characteristics, and therapeutic precis of RNA modification, m6A in particular, with the purpose of seeking the systematic regulation axis related to RNA modification to provide a better solution for the treatment of EC.

m6A modification of RNA in cervical cancer: role and clinical perspectives

The emerging roles of N6-methyladenosine RNA methylation in human cancers

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

A comprehensive review of m6A research in cervical cancer

The Roles of M6a RNA Modifiers in Human Cancer

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Mechanism of RNA Modification N6-methyladenosine in Human Cancer.

Roles of N6-methyladenosine (m6a) Modifications in Gynecologic Cancers: Mechanisms and Therapeutic Targeting

Role of N6-methyladenosine RNA modification in cancer

Shining a Spotlight on M6a and the Vital Role of RNA Modification in Endometrial Cancer: a Review

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer

Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy

Regulations of m6A and other RNA modifications and their roles in cancer

Emerging Roles of m<SUP>6</SUP>A RNA Methylation Regulators in Gynecological Cancer

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

Molecular Characterization and Clinical Relevance of m6A RNA Methylation Regulators in Cervical Cancer

Roles and Implications of Mrna N6 -Methyladenosine in Cancer.